Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 3—March 2021
Synopsis

Use of US Public Health Travel Restrictions during COVID-19 Outbreak on Diamond Princess Ship, Japan, February–April 2020

Alexandra M. MedleyComments to Author , Barbara J. Marston, Mitsuru Toda, Miwako Kobayashi, Michelle Weinberg, Leah F. Moriarty, M. Robynne Jungerman, Amethyst Clare A. Surpris, Barbara Knust, Anna M. Acosta, Caitlin E. Shockey, David Daigle, Zachary D. Schneider, Julia Charles, Atsuyoshi Ishizumi, Andrea Stewart, Laura A Vonnahme, Clive Brown, Stefanie White, Nicole J. Cohen, and Marty Cetron1
Author affiliation: Centers for Disease Control and Prevention, Atlanta, Georgia, USA

Main Article

Figure 3

Final disposition (hospitalized for COVID-19 vs. entered active monitoring) of US citizen passengers and crew of the Diamond Princess cruise ship who remained in Japan following US repatriation flights and were subject to public health travel restrictions during the COVID-19 outbreak, 2020. Repatriation flights occurred on February 17, 2020. The Diamond Princess cruise ship quarantine mandated by Japan ended on February 19,,2020; by that date, 67 persons had disembarked, 3 of whom had not tested positive for SARS-CoV-2 at that time. CDC, US Centers for Disease Control and Prevention; COVID-19, coronavirus disease; SARS-COV-2, severe acute respiratory syndrome coronavirus 2.

Figure 3. Final disposition (hospitalized for COVID-19 vs. entered active monitoring) of US citizen passengers and crew of the Diamond Princess cruise ship who remained in Japan following US repatriation flights and were subject to public health travel restrictions during the COVID-19 outbreak, 2020. Repatriation flights occurred on February 17, 2020. The Diamond Princess cruise ship quarantine mandated by Japan ended on February 19,,2020; by that date, 67 persons had disembarked, 3 of whom had not tested positive for SARS-CoV-2 at that time. CDC, US Centers for Disease Control and Prevention; COVID-19, coronavirus disease; SARS-COV-2, severe acute respiratory syndrome coronavirus 2.

Main Article

1Authors make up the Centers for Disease Control and Prevention COVID-19 Response Team.

Page created: January 20, 2021
Page updated: February 21, 2021
Page reviewed: February 21, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external